254 related articles for article (PubMed ID: 7743523)
1. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
2. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Bresalier RS; Byrd JC; Wang L; Raz A
Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 stimulates cell proliferation.
Inohara H; Akahani S; Raz A
Exp Cell Res; 1998 Dec; 245(2):294-302. PubMed ID: 9851870
[TBL] [Abstract][Full Text] [Related]
5. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
[TBL] [Abstract][Full Text] [Related]
6. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
7. Identification of human melanoma cellular and secreted ligands for galectin-3.
Inohara H; Raz A
Biochem Biophys Res Commun; 1994 Jun; 201(3):1366-75. PubMed ID: 8024581
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3, a laminin binding protein, fails to modulate adhesion of human melanoma cells to laminin.
van den Brûle FA; Buicu C; Sobel ME; Liu FT; Castronovo V
Neoplasma; 1995; 42(5):215-9. PubMed ID: 8552198
[TBL] [Abstract][Full Text] [Related]
9. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis.
Ilantzis C; Jothy S; Alpert LC; Draber P; Stanners CP
Lab Invest; 1997 May; 76(5):703-16. PubMed ID: 9166289
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
[TBL] [Abstract][Full Text] [Related]
11. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
12. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3.
Warfield PR; Makker PN; Raz A; Ochieng J
Invasion Metastasis; 1997; 17(2):101-12. PubMed ID: 9561029
[TBL] [Abstract][Full Text] [Related]
13. Are matrix-immobilized neoglycoproteins, plant and human lectins and carbohydrate--binding antibodies from human serum mediators of adhesion in vitro for carcinoma and lymphosarcoma cells?
Wawotzny R; André S; Dong X; Joshi SS; Gabius HJ
Anticancer Res; 1995; 15(1):169-74. PubMed ID: 7733629
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of endogenous galectin-1 and galectin-3 in human prostate cancer cell lines and effects of overexpressing galectin-1 on cell phenotype.
Ellerhorst J; Nguyen T; Cooper DN; Lotan D; Lotan R
Int J Oncol; 1999 Feb; 14(2):217-24. PubMed ID: 9917495
[TBL] [Abstract][Full Text] [Related]
15. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD66a and CD66b as the major galectin-3 receptor candidates in human neutrophils.
Feuk-Lagerstedt E; Jordan ET; Leffler H; Dahlgren C; Karlsson A
J Immunol; 1999 Nov; 163(10):5592-8. PubMed ID: 10553088
[TBL] [Abstract][Full Text] [Related]
17. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
Betka J; Plzák J; Smetana K; Gabius HJ
Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
[TBL] [Abstract][Full Text] [Related]
19. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
Inohara H; Akahani S; Koths K; Raz A
Cancer Res; 1996 Oct; 56(19):4530-4. PubMed ID: 8813152
[TBL] [Abstract][Full Text] [Related]
20. Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells.
Sarafian V; Jadot M; Foidart JM; Letesson JJ; Van den Brûle F; Castronovo V; Wattiaux R; Coninck SW
Int J Cancer; 1998 Jan; 75(1):105-11. PubMed ID: 9426697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
